⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL234714 | 1.00 | — | — | |
| SCHEMBL16599029 | 0.78 | GABRR1 (0.32) | — | |
| SCHEMBL16599026 | 0.78 | GABRR1 (0.32) | — | |
| SCHEMBL16599027 | 0.78 | GABRR1 (0.32) | — | |
| SCHEMBL9328915 | 0.75 | GRIK1 (0.32) | — | |
| SCHEMBL16751247 | 0.74 | CYP2C19 (0.35) | — | |
| SCHEMBL7966032 | 0.73 | — | — | |
| SCHEMBL7966029 | 0.73 | — | — | |
| SCHEMBL7807832 | 0.71 | ALDH1A1 (0.42) | — | |
| SCHEMBL7807829 | 0.71 | ALDH1A1 (0.42) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240307371-A1 | BENZOQUINOLINE INHIBITORS OF VESICULAR MONOAMINE TRANSPORTER 2 | AUSPEX PHARMACEUTICALS LLC | 2024-09-19 | — | — | US | disclosed |
| US-20230122780-A1 | BENZOQUINOLINE INHIBITORS OF VESICULAR MONOAMINE TRANSPORTER 2 | AUSPEX PHARMACEUTICALS INC (US) | 2023-04-20 | — | — | US | disclosed |
| US-20200281917-A1 | BENZOQUINOLINE INHIBITORS OF VESICULAR MONOAMINE TRANSPORTER 2 | AUSPEX PHARMACEUTICALS, INC. | 2020-09-10 | — | — | US | disclosed |
| EP-3398602-A1 | BENZOQUINOLINE INHIBITORS OF VESICULAR MONOAMINE TRANSPORTER 2 | Auspex Pharmaceuticals, Inc. (US) | 2018-11-07 | — | — | EP | disclosed |
| EP-3351247-A1 | BENZOQUINOLONE INHIBITORS OF VMAT2 | Auspex Pharmaceutical, Inc. (US) | 2018-07-25 | — | — | EP | disclosed |
| US-20180169087-A1 | BENZOQUINOLINE INHIBITORS OF VESICULAR MONOAMINE TRANSPORTER 2 | AUSPEX PHARMACEUTICALS INC (US) | 2018-06-21 | — | — | US | disclosed |
| US-20180169087-A1 | BENZOQUINOLINE INHIBITORS OF VESICULAR MONOAMINE TRANSPORTER 2 | AUSPEX PHARMACEUTICALS INC (US) | 2018-06-21 | — | — | US | disclosed |
| US-20170246159-A1 | BENZOQUINOLONE INHIBITORS OF VMAT2 | AUSPEX PHARMACEUTICALS INC (US) | 2017-08-31 | — | — | US | disclosed |
| US-20170246159-A1 | BENZOQUINOLONE INHIBITORS OF VMAT2 | AUSPEX PHARMACEUTICALS INC (US) | 2017-08-31 | — | — | US | disclosed |
| EP-3099299-A1 | BENZOQUINOLINE INHIBITORS OF VESICULAR MONOAMINE TRANSPORTER 2 | Auspex Pharmaceuticals, Inc. (US) | 2016-12-07 | — | — | EP | disclosed |
| WO-2015077520-A1 | METHODS OF TREATING ABNORMAL MUSCULAR ACTIVITY | AUSPEX PHARMACEUTICALS, INC. (US) | 2015-05-28 | — | — | WO | disclosed |
| WO-2015077520-A1 | METHODS OF TREATING ABNORMAL MUSCULAR ACTIVITY | AUSPEX PHARMACEUTICALS, INC. (US) | 2015-05-28 | — | — | WO | disclosed |
| WO-2015077521-A1 | BENZOQUINOLINE INHIBITORS OF VESICULAR MONOAMINE TRANSPORTER 2 | AUSPEX PHARMACEUTICALS, INC. (US) | 2015-05-28 | — | — | WO | disclosed |
| US-20150080426-A1 | BENZOQUINOLINE INHIBITORS OF VMAT 2 | AUSPEX PHARMACEUTICALS, INC. | 2015-03-19 | — | — | US | disclosed |
| US-20150080426-A1 | BENZOQUINOLINE INHIBITORS OF VMAT 2 | AUSPEX PHARMACEUTICALS, INC. | 2015-03-19 | — | — | US | disclosed |
| EP-2576552-A2 | BENZOQUINOLONE INHIBITORS OF VMAT2 | Aupex Pharmaceutical, Inc. (US) | 2013-04-10 | — | — | EP | disclosed |
| US-20120003330-A1 | BENZOQUINOLONE INHIBITORS OF VMAT2 | AUSPEX PHARMACEUTICALS, INC. (US) | 2012-01-05 | — | — | US | disclosed |
| US-20120003330-A1 | BENZOQUINOLONE INHIBITORS OF VMAT2 | AUSPEX PHARMACEUTICALS, INC. (US) | 2012-01-05 | — | — | US | disclosed |
| WO-2011153157-A2 | BENZOQUINOLONE INHIBITORS OF VMAT2 | AUSPEX PHARMACEUTICAL, INC. (US) | 2011-12-08 | — | — | WO | disclosed |
| WO-2011153157-A2 | BENZOQUINOLONE INHIBITORS OF VMAT2 | AUSPEX PHARMACEUTICAL, INC. (US) | 2011-12-08 | — | — | WO | disclosed |